Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MPC Aims at Becoming Global Pharma through Holding Company
May 23, 2005
- Spiriva Can Cut COPD Treatment Cost by ¥59 Bil. a Year
May 23, 2005
- Discovering 2 to 3 New Drug Candidates a Year "Achievable": Tanabe Seiyaku
May 23, 2005
- PMDA to Restart Receiving Applications for Clinical Trial Consultation
May 23, 2005
- Santen: Domestic Market Spurs Growth in Sales
May 23, 2005
- PMDA Expediting the Review Process
May 23, 2005
- Kaken: Sales Up 3% to \74,922 Mil.
May 23, 2005
- Chuikyo Recommends Approval of Shionogi's Doripenem
May 23, 2005
- Taisho: Self-medication Sales Down 2.5% to \183,416 Mil.
May 23, 2005
- Central, Local Gov't Must Cooperate Closely to Effectively Implement Amended PAL
May 23, 2005
- Kyorin: Sales Up 1.9% to \66,296 Mil.
May 23, 2005
- Approval Standards Established for 3 Dietary Fibers, 6 Oligosaccharides
May 23, 2005
- Sumitomo Pharm.: Sales Up 4.0% to \142,347 Mil.
May 23, 2005
- GL to Assess Equivalency of Biological Products Announced
May 23, 2005
- Asahi Kasei Pharma: Sales Fall 1.9% to \103,930 Mil.
May 23, 2005
- REGULATORY NEWS IN BRIEF
May 23, 2005
- Nippon Shinyaku: Major Products Prop Up Sales
May 23, 2005
- Daiichi Sankyo Aims at \932 Bil. in FY2009
May 23, 2005
- Tsumura: Drug Sales Up 4.1% to \70,805 Mil.
May 23, 2005
- BUSINESS NEWS IN BRIEF
May 23, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…